EUCTR2017-002574-39-DE进行中（未招募）1 期
Ancillary study evaluating ChAd155-hIi-HBV shedding in a subset of chronic hepatitis B patients enrolled in the first-time-in-human, Phase I/II, randomised, multi-centric, single-blind study TH HBV VV-001 - TH HBV VV-031 HBS:001
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 76
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients who, in the opinion of the investigator, can and will comply with the requirements of the protocol.
- •Written informed consent obtained from the patient prior to performance of any study specific procedure.
- •Patients who met all inclusion criteria and were randomised to the Step B of the TH HBV VV-001 study.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 38
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 38
排除标准
- •Patients met any exclusion criterion of the TH HBV VV-001 study.
研究者
相似试验
已完成
不适用
Clinical Study of evaluation of inactive HBV carriers by HBsAg quantificatioJPRN-UMIN000012704Chiba Univerisity100
已完成
4 期
Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHBChronic Hepatitis BNCT01320943Gilead Sciences43
已完成
1 期
A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid TumorsJPRN-jRCT2080225314AbbVie G.K.27
已完成
不适用
Evaluation of the effect of HBF2020-05 intake on visual function.Healthy Japanease adultsJPRN-UMIN000045803Hayashibara CO., LTD.32
招募中
不适用
A Phase 1 First-in-Human Study with ABBV-155 Alone and in Combination with Taxane Therapy in Adults with Relapsed and/or Refractory Tumors(non) small cell lunger cancer + breast cancer10027655NL-OMON55246AbbVie Deutschland GmbH & Co. KG10